Oncogenomics lab

The focus of our research is to identify targetable genetic alterations in epithelial cancers to find oncogenic drivers and molecular markers that associate with drug sensitivity and resistance using different in vitro and ex vivo tumor models. Our group is part of the Applied Tumor Genomics Research Program at the Faculty of Medicine, University of Helsinki. Monnilab operates in close connection with Biomedicum Functional Genomics Unit (FuGU), which provides services in genome analyses and is part of the HiLIFE Genome Analysis Infrastructure.